Appointments at INC Research, DPT, PharmaNet and CTI – People on the move
Jeffrey Freitag has expanded his role at PharmaNet Development Group to become chief medical officer. Freitag will continue as senior vice president, PharmaNet Consulting. Before rejoining PharmaNet in 2006 Freitag worked at Bone Care International.
INC Research has hired Patrick Melvin as executive director, oncology. Melvin has 20 years of drug development experience, in haematology and oncology, at companies including PPD and Premier Research.
Grant Gilker has been named general manager, operations for the DPT Laboratories’ semi-solids and liquids manufacturing facility in San Antonio, Texas, US. Gilker has 21 years of pharma manufacturing experience working at companies including Pharmetics and Patheon.
DPT has also appointed Luis Velez as director of development services. Velez has 15 years of experience in the pharmaceutical industry, most recently at Cordis USA as new products transfer director.
Paul Viggers has joined Biotec Services as project manager. Viggers worked for the Welsh Assembly Government for 12 years, during which time he worked with Biotec to support its international expansion.
CTI Clinical Trial and Consulting Services has promoted Catherine Klose to director, business development and client management. Klose joined CTI in 2009 having previously worked Astellas Pharma. Also, CTI has promoted Meredith Boley to regulatory specialist.
Reneé Smith has joined Metrics to fill a newly-created validation manager position. Hiring Smith centralises oversight of validation activities and a multi-disciplinary team, which used to handle the task, will now assist her.
Pharm-Olam International (POI) has named Maria Verdugo as head of its new ophthalmology unit. Verdugo is also chief scientific officer at POI and has previously worked at Alcon and Allergan.
Brad Gien has been hired by BASi to work in its Culex services team. BASi recently added the ability to work with large animals and hired Gien in conjunction with this expansion.
